What is the market doing?
What the tape says about TARS
Tarsus Pharmaceuticals, Inc. is +60% over the past year while the S&P 500 is +20%: 39 points ahead of the market.
+60%
1-year return · S&P 500 +20%
- vs 200-day average
- +26%
vs 200-day average · a clear uptrend
- RSI (14)
- 76
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 4.0%
Below its 52-week high
Details›
- Last close2026-09-08
- $87.21
- 1 monthS&P 500 −0.30%
- +33%
- 1 yearS&P 500 +20%
- +60%
- 5 yearsS&P 500 +85%
- +248%
- vs 50-day average$66.20
- +32%
- 52-week high
- $90.81
- 52-week low
- $49.36
- Annualised volatility
- 49%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$7.1M
| Year | Return |
|---|---|
| 2026 (year to date) | +6.5% |
| 2025 | +48% |
| 2024 | +173% |
| 2023 | +38% |
| 2022 | −35% |
| 2021 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | −0.27% |
| Feb | 6 | 2 of 6 | +3.7% |
| Mar | 6 | 1 of 6 | −5.2% |
| Apr | 6 | 3 of 6 | +0.18% |
| May | 6 | 3 of 6 | −3.9% |
| Jun | 6 | 3 of 6 | −2.3% |
| Jul | 6 | 2 of 6 | −3.4% |
| Aug | 6 | 5 of 6 | +15% |
| Sep | 6 | 5 of 6 | +5.7% |
| Oct | 5 | 4 of 5 | +14% |
| Nov | 6 | 4 of 6 | +9.3% |
| Dec | 6 | 4 of 6 | +12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.